ESSAI CLINIQUE No essai ClinicalTrials.gov ID |
Investigateur(trice) principal(e)
Coordonnateur(rice) |
||
---|---|---|---|
(EN) A Phase 2 Study of Blinatumomab in Combination With Nivolumab, a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged ? 1 to < 31 Years Old With First Relapse
COG-AALL1821 NCT04546399 ![]() |
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Leucémie lymphoide aiguë (LLA) |
Dr Yvan Samson |